Here’s whether 10x Genomics, Inc. Class A Common Stock (TXG) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+14.09% over 10 days); strong 1-year return of +323.6%; 3-month momentum positive (+164.6%). Currently 7.6% off its 52-week high. Score: +6/7.
TXG is in a confirmed uptrend, trading above both its 50-day ($41.74) and 200-day ($25.37) moving averages. An RSI of 69.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +323.6% compares to +20.4% for SPY (beat the market by 303.3%).
$10,000 invested 1 year ago→ $42,364 today
vs. S&P 500 (SPY) — same period beat market by 303.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($25.37)
✓Above 50-day MA ($41.74)
✓RSI(14) neutral zone (30–70) — currently 69.0
✓Positive return (+323.6%)
✓Within 10% of period high (−7.6%)
Period Range $56.09
$11.16$60.69
RSI (14) 69.0
0 · OversoldOverbought · 100
Key Metrics
Price$56.09
Period Return+323.6%
Period High$60.69
Period Low$11.16
Drawdown−7.6%
MA-50$41.74
MA-200$25.37
RSI (14)69.0
Avg Volume (30d)3.1M
vs. SPYbeat by 303.3%
Return Rank#26 of 1252
Trend Signals
Price is above the 200-day moving average ($25.37)